ATE114114T1 - Verwendung von benzimidazol-derivaten als antibakterielle mittel. - Google Patents
Verwendung von benzimidazol-derivaten als antibakterielle mittel.Info
- Publication number
- ATE114114T1 ATE114114T1 AT90301256T AT90301256T ATE114114T1 AT E114114 T1 ATE114114 T1 AT E114114T1 AT 90301256 T AT90301256 T AT 90301256T AT 90301256 T AT90301256 T AT 90301256T AT E114114 T1 ATE114114 T1 AT E114114T1
- Authority
- AT
- Austria
- Prior art keywords
- antibacterial agents
- benzimidazole derivatives
- stands
- hydrogen
- campylobacter
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000589876 Campylobacter Species 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000590002 Helicobacter pylori Species 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3237489 | 1989-02-10 | ||
| JP23923389 | 1989-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE114114T1 true ATE114114T1 (de) | 1994-12-15 |
Family
ID=26370930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90301256T ATE114114T1 (de) | 1989-02-10 | 1990-02-06 | Verwendung von benzimidazol-derivaten als antibakterielle mittel. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5013743A (de) |
| EP (1) | EP0382489B1 (de) |
| AT (1) | ATE114114T1 (de) |
| CA (1) | CA2009741C (de) |
| DE (1) | DE69014141T2 (de) |
| DK (1) | DK0382489T3 (de) |
| ES (1) | ES2066120T3 (de) |
| FI (2) | FI100168B (de) |
| GR (1) | GR3014973T3 (de) |
| NO (1) | NO900639L (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338723A (en) * | 1989-10-13 | 1994-08-16 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| ATE209914T1 (de) * | 1990-09-14 | 2001-12-15 | Byk Gulden Lomberg Chem Fab | Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen |
| TW209174B (de) * | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
| IS3990A (is) * | 1992-04-24 | 1993-10-25 | Ab Astra | Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi |
| US5504082A (en) * | 1992-06-01 | 1996-04-02 | Yoshitomi Pharmaceutical Industries, Ltd. | Pyridine compound and pharmaceutical compostions |
| BR9306702A (pt) * | 1992-07-08 | 1998-12-08 | Monsanto Co | Benzimidazóis para aliviar úlceras estomacais em suínos |
| EP0652751B1 (de) * | 1992-07-28 | 1996-10-23 | Astra Aktiebolag | Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten |
| EP0585722B1 (de) * | 1992-08-21 | 1996-05-15 | Eisai Co., Ltd. | Benzimidazolverbindungen als Antibiotika gegen Campylobacter pylon |
| EP0673246A1 (de) * | 1992-12-10 | 1995-09-27 | Byk Gulden Lomberg Chemische Fabrik GmbH | Verwendung von alkylthiopyridinen zur bekämpfung von heliobacter-bakterien |
| JPH06298611A (ja) * | 1993-04-16 | 1994-10-25 | Nippon Chemiphar Co Ltd | 抗菌剤 |
| DK0706523T3 (da) * | 1993-06-29 | 2001-06-18 | Byk Gulden Lomberg Chem Fab | Substituerede arylthioalkylthiopyridiner |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| US8071128B2 (en) * | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| US6861448B2 (en) * | 1998-01-14 | 2005-03-01 | Virtual Drug Development, Inc. | NAD synthetase inhibitors and uses thereof |
| JP2002509149A (ja) | 1998-01-14 | 2002-03-26 | ザ ユーエイビー リサーチ ファウンデイション | 細菌nadシンテターゼ酵素の阻害剤の合成およびスクリーニング方法、その化合物、ならびに細菌nadシンテターゼ酵素の阻害剤を用いる細菌および微生物感染の治療方法 |
| FI104384B (fi) | 1998-06-05 | 2000-01-14 | Valmet Corp | Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa |
| CA2419067C (en) | 2000-08-18 | 2008-12-23 | Takeda Chemical Industries, Ltd. | Injectable composition comprising benzimidazole compound and strong alkali |
| JP4020076B2 (ja) | 2001-09-18 | 2007-12-12 | ゼリア新薬工業株式会社 | ベンズイミダゾール誘導体 |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| US20040006111A1 (en) * | 2002-01-25 | 2004-01-08 | Kenneth Widder | Transmucosal delivery of proton pump inhibitors |
| US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| EP1603537A4 (de) * | 2003-02-20 | 2009-11-04 | Santarus Inc | Neuartige formulierung, antazidkomplex-immediatfreisetzung für eine schnelle und anhaltende unterdrückung von magensäure |
| JP2006528182A (ja) * | 2003-07-18 | 2006-12-14 | サンタラス インコーポレイティッド | 薬学的製剤および酸に起因する消化器疾患の治療法 |
| US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| JP2006528181A (ja) * | 2003-07-18 | 2006-12-14 | サンタラス インコーポレイティッド | 酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法 |
| US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
| JP2007522217A (ja) * | 2004-02-10 | 2007-08-09 | サンタラス インコーポレイティッド | プロトンポンプ阻害剤、緩衝剤および非ステロイド系抗炎症薬の組み合わせ |
| US20050239845A1 (en) * | 2004-04-16 | 2005-10-27 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
| US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20060024362A1 (en) * | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
| US8747895B2 (en) * | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) * | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| AU2005299490C1 (en) | 2004-10-21 | 2012-01-19 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| US7598273B2 (en) * | 2005-10-06 | 2009-10-06 | Auspex Pharmaceuticals, Inc | Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties |
| PL2003130T3 (pl) * | 2006-03-10 | 2012-04-30 | Link Genomics Inc | Nowa pochodna pirydyny o aktywności przeciwko helicobacter pylori |
| WO2007138606A2 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
| EP2023721A2 (de) * | 2006-06-05 | 2009-02-18 | Auspex Pharmaceuticals Inc. | Herstellung und verwendung substituierter erythromycin-analoge |
| CA2665226C (en) | 2006-10-05 | 2014-05-13 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| AU2007317561A1 (en) | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
| BRPI1014314A2 (pt) * | 2009-04-09 | 2019-09-24 | Arigen Pharmaceuticals Inc | derivado de tiopiridina, e, composição farmacêutica. |
| KR101765357B1 (ko) | 2009-12-02 | 2017-08-04 | 아데어 파마수티컬스 에스.알.엘. | 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물 |
| AR079862A1 (es) * | 2010-01-08 | 2012-02-22 | Eurand Inc | Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion |
| US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| JP2694361B2 (ja) * | 1989-02-09 | 1997-12-24 | アストラ アクチエボラグ | 抗菌剤 |
-
1990
- 1990-02-06 DK DK90301256.5T patent/DK0382489T3/da active
- 1990-02-06 ES ES90301256T patent/ES2066120T3/es not_active Expired - Lifetime
- 1990-02-06 DE DE69014141T patent/DE69014141T2/de not_active Expired - Lifetime
- 1990-02-06 EP EP90301256A patent/EP0382489B1/de not_active Expired - Lifetime
- 1990-02-06 AT AT90301256T patent/ATE114114T1/de active
- 1990-02-09 FI FI900662A patent/FI100168B/fi active IP Right Grant
- 1990-02-09 NO NO90900639A patent/NO900639L/no unknown
- 1990-02-09 CA CA002009741A patent/CA2009741C/en not_active Expired - Lifetime
- 1990-02-12 US US07/478,405 patent/US5013743A/en not_active Expired - Lifetime
-
1994
- 1994-02-28 FI FI940951A patent/FI104045B/fi active
-
1995
- 1995-02-08 GR GR940403729T patent/GR3014973T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI104045B1 (fi) | 1999-11-15 |
| FI100168B (fi) | 1997-10-15 |
| FI900662A0 (fi) | 1990-02-09 |
| CA2009741A1 (en) | 1990-08-10 |
| NO900639D0 (no) | 1990-02-09 |
| NO900639L (no) | 1990-08-13 |
| FI940951A0 (fi) | 1994-02-28 |
| DE69014141T2 (de) | 1995-05-24 |
| CA2009741C (en) | 1999-03-23 |
| FI104045B (fi) | 1999-11-15 |
| DK0382489T3 (da) | 1995-01-16 |
| GR3014973T3 (en) | 1995-05-31 |
| ES2066120T3 (es) | 1995-03-01 |
| EP0382489A2 (de) | 1990-08-16 |
| EP0382489B1 (de) | 1994-11-17 |
| EP0382489A3 (de) | 1991-06-12 |
| DE69014141D1 (de) | 1994-12-22 |
| US5013743A (en) | 1991-05-07 |
| FI940951L (fi) | 1994-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69014141D1 (de) | Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel. | |
| DE69331774D1 (de) | 7-Substituierte-8-substituierte-9-substituierte Amino-7-Demethyl-6-Deoxy-Tetracycline als antibiotische Mittel | |
| BG106390A (en) | Novel spiro compounds | |
| ATE82966T1 (de) | Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel. | |
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| DE69716925D1 (de) | Isoxazoline derivate und ihre verwendung als antimikroben | |
| NO304983B1 (no) | Nye fosfinyloksymetylketoner, farmas°ytisk sammensetning og anvendelse derav | |
| NO934718L (no) | Nye HIV protease inhibitorer | |
| NO953052L (no) | Nye pyrrolokarbazoler | |
| DE69231422D1 (de) | Pyridoncarbonsäurederivate | |
| ATE159728T1 (de) | Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung | |
| YU83993A (sh) | Novi derivati piridon organske kiseline | |
| ATE209633T1 (de) | Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel | |
| MXPA02011234A (es) | Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas. | |
| ATE279191T1 (de) | Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel | |
| ATE119523T1 (de) | Isochinolinderivate und ihre salze als proteasehemmer. | |
| ATE275560T1 (de) | Bemzimidazolverbindungen und medikamente die diese enthalten | |
| DE69837628D1 (de) | Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel | |
| YU239790A (sh) | Sredstva za zatiranje škodljivcev | |
| ATE222255T1 (de) | 14-substituierte marcfortine und derivate als antiparasitäre mittel | |
| ATE141918T1 (de) | Isoquinolinderivate | |
| DK0421668T3 (da) | 1,4-dihydro-4-oxo-3-quinolinderivater som selektivt toksiske, antibakterielle midler til pattedyr | |
| ES2090056T3 (es) | Derivados de pirroloquinolina, su utilizacion como agentes antimicrobianos y procedimientos para su preparacion. | |
| TH16093A (th) | สารประกอบชนิดใหม่ |